NEW YORK (CBSNewYork) — Meridian Medical Technologies, makers of Mylan's EpiPen Auto-Injector, have issued a voluntary recall of its EpiPen and EpiPen Jr. injectors. "The potential defect could make ...
CVS Health, which owns more than 9,600 retail pharmacies and 1,100 walk-in clinics, will offer a lower-cost generic version of the Adrenaclick epinephrine auto-injector, targeting Mylan after the ...
WASHINGTON (Reuters) -The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive its antitrust lawsuit accusing rival pharmaceutical company Viatris Inc of illegally monopolizing ...
Canonsburg, Pa.-based Mylan has come under fire for its high pricing of EpiPen. However, Americans keep purchasing the drug despite a less expensive and equally safe alternative being available on the ...
While EpiPen prescriptions are still increasing, Mylan’s share of the epinephrine auto-injector market fell for the first time in three years, according to research from athenahealth. The analysis is ...
* Mylan says authorized generic, which will reach pharmacies starting next week, has same drug formulation and device functionality as Epipen auto-injector Sign up here. * Authorized generic for ...
Mylan and federal investigators Thursday finalized a $465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication EpiPen. Resolving an issue that ...
* Is reducing patient cost of epipen( ) auto-injector through use of a savings card which will cover up to $300 for their epipen 2-pak * Doubling eligibility for its patient assistance program, which ...
June 29 (Reuters) - Drugmaker Sanofi SASY.PA asked a U.S. judge on Wednesday to curb Mylan's bid to recover litigation costs in an antitrust lawsuit, calling the rival pharmaceutical company's court ...
While numerous companies attempted to set foot in the epinephrine auto-injection market, none were able to significantly impact Canonsburg, Pa.-based Mylan’s control of the market. This dominance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results